Voluntary price reduction of generic products in the NSAID ‘celecoxib’ war
As the patent of the selective COX-2 inhibition anti-inflammatory drug ‘Celebrex(generic name: celecoxib)’ will be expired on the coming 11th of June, approximately 100 generics are expected to be poured out.
Since its launch in 2000, the drug, recoding KRW 56.5 billion health insurance fees las...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
